RANI
Rani Therapeutics Holdings
$0.81
−$0.04 (−4.82%)Jul 27, 2026
Key metrics
The numbers that frame RANI today
- Market cap
- $100.35M
- P/E (TTM)
- -3.4
- EV / FCF
- -5.5
- Gross margin
- 100%
- EV / Sales
- 29.9
- ROIC
- -144.1%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.44
- 52wk High
- $3.87
Growth
Revenue and earnings trend for RANI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RANI
Is Rani Therapeutics Holdings a good buy?
No. Rani Therapeutics Holdings has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Rani Therapeutics Holdings is selling at a very high price.
What is the market capitalization of RANI?
Rani Therapeutics Holdings's market capitalization is $100.35M.
What is the P/E ratio for RANI stock?
Rani Therapeutics Holdings's current P/E ratio is -3.4.
What is the 52-week high for RANI stock?
The 52-week high for Rani Therapeutics Holdings is $3.87. The current close of $0.81 is 79.1% below that high.
What is the 52-week low for RANI stock?
The 52-week low for Rani Therapeutics Holdings is $0.44. The current close of $0.81 is 84.1% above that low.
Does RANI stock pay dividends?
Rani Therapeutics Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RANI?
Rani Therapeutics Holdings's Debt / Equity ratio is 0.14.